Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery.

Trial Profile

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2017

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
    • 17 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
    • 09 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top